A majority (59.5%) of the patients were on oral anti diabetic agents (OAD) alone, followed by 22.2% on combination therapy of OAD plus insulin, 10.8% on insulin alone and 7.6% of the participants were not on any pharmacotherapy for diabetes. This evidence concerns the gene INS and diabetes mellitus.